Mollusc-Derived Brominated Indoles for the Selective Inhibition of Cyclooxygenase: A Computational Expedition

Inflammation plays an important role in different chronic diseases. Brominated indoles derived from the Australian marine mollusk <i>Dicathais orbita</i> (<i>D. orbita</i>) are of interest for their anti-inflammatory properties. This study evaluates the binding mechanism and...

Full description

Bibliographic Details
Main Authors: Md. Mominur Rahman, Md. Junaid, S. M. Zahid Hosen, Mohammad Mostafa, Lei Liu, Kirsten Benkendorff
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/21/6538
_version_ 1827678047174656000
author Md. Mominur Rahman
Md. Junaid
S. M. Zahid Hosen
Mohammad Mostafa
Lei Liu
Kirsten Benkendorff
author_facet Md. Mominur Rahman
Md. Junaid
S. M. Zahid Hosen
Mohammad Mostafa
Lei Liu
Kirsten Benkendorff
author_sort Md. Mominur Rahman
collection DOAJ
description Inflammation plays an important role in different chronic diseases. Brominated indoles derived from the Australian marine mollusk <i>Dicathais orbita</i> (<i>D. orbita</i>) are of interest for their anti-inflammatory properties. This study evaluates the binding mechanism and potentiality of several brominated indoles (tyrindoxyl sulfate, tyrindoleninone, 6-bromoisatin, and 6,6′-dibromoindirubin) against inflammatory mediators cyclooxygenases-1/2 (COX-1/2) using molecular docking, followed by molecular dynamics simulation, along with physicochemical, drug-likeness, pharmacokinetic (pk), and toxicokinetic (tk) properties. Molecular docking identified that these indole compounds are anchored, with the main amino acid residues, positioned in the binding pocket of the COX-1/2, required for selective inhibition. Moreover, the molecular dynamics simulation based on root mean square deviation (RMSD), radius of gyration (Rg), solvent accessible surface area (SASA), and root mean square fluctuation (RMSF) analyses showed that these natural brominated molecules transit rapidly to a progressive constant configuration during binding with COX-1/2 and seem to accomplish a consistent dynamic behavior by maintaining conformational stability and compactness. The results were comparable to the Food and Drug Administration (FDA)-approved selective COX inhibitor, aspirin. Furthermore, the free energy of binding for the compounds assessed by molecular mechanics–Poisson–Boltzmann surface area (MM–PBSA) confirmed the binding capacity of indoles towards COX-1/2, with suitable binding energy values except for the polar precursor tyrindoxyl sulfate (with COX-1). The physicochemical and drug-likeness analysis showed zero violations of Lipinski’s rule, and the compounds are predicted to have excellent pharmacokinetic profiles. These indoles are projected to be non-mutagenic and free from hepatotoxicity, with no inhibition of human <i>ether-a-go–go gene (hERG) I</i> inhibitors, and the oral acute toxicity LD<sub>50</sub> in rats is predicted to be similar or lower than aspirin. Overall, this work has identified a plausible mechanism for selective COX inhibition by natural marine indoles as potential therapeutic candidates for the mitigation of inflammation.
first_indexed 2024-03-10T05:56:08Z
format Article
id doaj.art-bdb23c99f66342c795c5dd71e575be79
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T05:56:08Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-bdb23c99f66342c795c5dd71e575be792023-11-22T21:22:49ZengMDPI AGMolecules1420-30492021-10-012621653810.3390/molecules26216538Mollusc-Derived Brominated Indoles for the Selective Inhibition of Cyclooxygenase: A Computational ExpeditionMd. Mominur Rahman0Md. Junaid1S. M. Zahid Hosen2Mohammad Mostafa3Lei Liu4Kirsten Benkendorff5Marine Ecology Research Centre, Faculty of Science and Engineering, Southern Cross University, Lismore, NSW 2480, AustraliaMolecular Modeling Drug-design and Discovery Laboratory, Pharmacology Research Division, BCSIR Laboratories Chattogram, Bangladesh Council of Scientific and Industrial Research, Chattogram 4217, BangladeshMolecular Modeling Drug-design and Discovery Laboratory, Pharmacology Research Division, BCSIR Laboratories Chattogram, Bangladesh Council of Scientific and Industrial Research, Chattogram 4217, BangladeshMolecular Modeling Drug-design and Discovery Laboratory, Pharmacology Research Division, BCSIR Laboratories Chattogram, Bangladesh Council of Scientific and Industrial Research, Chattogram 4217, BangladeshSouthern Cross Plant Science, Faculty of Science and Engineering, Southern Cross University, Lismore, NSW 2480, AustraliaMarine Ecology Research Centre, Faculty of Science and Engineering, Southern Cross University, Lismore, NSW 2480, AustraliaInflammation plays an important role in different chronic diseases. Brominated indoles derived from the Australian marine mollusk <i>Dicathais orbita</i> (<i>D. orbita</i>) are of interest for their anti-inflammatory properties. This study evaluates the binding mechanism and potentiality of several brominated indoles (tyrindoxyl sulfate, tyrindoleninone, 6-bromoisatin, and 6,6′-dibromoindirubin) against inflammatory mediators cyclooxygenases-1/2 (COX-1/2) using molecular docking, followed by molecular dynamics simulation, along with physicochemical, drug-likeness, pharmacokinetic (pk), and toxicokinetic (tk) properties. Molecular docking identified that these indole compounds are anchored, with the main amino acid residues, positioned in the binding pocket of the COX-1/2, required for selective inhibition. Moreover, the molecular dynamics simulation based on root mean square deviation (RMSD), radius of gyration (Rg), solvent accessible surface area (SASA), and root mean square fluctuation (RMSF) analyses showed that these natural brominated molecules transit rapidly to a progressive constant configuration during binding with COX-1/2 and seem to accomplish a consistent dynamic behavior by maintaining conformational stability and compactness. The results were comparable to the Food and Drug Administration (FDA)-approved selective COX inhibitor, aspirin. Furthermore, the free energy of binding for the compounds assessed by molecular mechanics–Poisson–Boltzmann surface area (MM–PBSA) confirmed the binding capacity of indoles towards COX-1/2, with suitable binding energy values except for the polar precursor tyrindoxyl sulfate (with COX-1). The physicochemical and drug-likeness analysis showed zero violations of Lipinski’s rule, and the compounds are predicted to have excellent pharmacokinetic profiles. These indoles are projected to be non-mutagenic and free from hepatotoxicity, with no inhibition of human <i>ether-a-go–go gene (hERG) I</i> inhibitors, and the oral acute toxicity LD<sub>50</sub> in rats is predicted to be similar or lower than aspirin. Overall, this work has identified a plausible mechanism for selective COX inhibition by natural marine indoles as potential therapeutic candidates for the mitigation of inflammation.https://www.mdpi.com/1420-3049/26/21/6538<i>Dicathais orbita</i>inflammationCOX-1/2molecular dockingmolecular dynamicsdrug-likeness
spellingShingle Md. Mominur Rahman
Md. Junaid
S. M. Zahid Hosen
Mohammad Mostafa
Lei Liu
Kirsten Benkendorff
Mollusc-Derived Brominated Indoles for the Selective Inhibition of Cyclooxygenase: A Computational Expedition
Molecules
<i>Dicathais orbita</i>
inflammation
COX-1/2
molecular docking
molecular dynamics
drug-likeness
title Mollusc-Derived Brominated Indoles for the Selective Inhibition of Cyclooxygenase: A Computational Expedition
title_full Mollusc-Derived Brominated Indoles for the Selective Inhibition of Cyclooxygenase: A Computational Expedition
title_fullStr Mollusc-Derived Brominated Indoles for the Selective Inhibition of Cyclooxygenase: A Computational Expedition
title_full_unstemmed Mollusc-Derived Brominated Indoles for the Selective Inhibition of Cyclooxygenase: A Computational Expedition
title_short Mollusc-Derived Brominated Indoles for the Selective Inhibition of Cyclooxygenase: A Computational Expedition
title_sort mollusc derived brominated indoles for the selective inhibition of cyclooxygenase a computational expedition
topic <i>Dicathais orbita</i>
inflammation
COX-1/2
molecular docking
molecular dynamics
drug-likeness
url https://www.mdpi.com/1420-3049/26/21/6538
work_keys_str_mv AT mdmominurrahman molluscderivedbrominatedindolesfortheselectiveinhibitionofcyclooxygenaseacomputationalexpedition
AT mdjunaid molluscderivedbrominatedindolesfortheselectiveinhibitionofcyclooxygenaseacomputationalexpedition
AT smzahidhosen molluscderivedbrominatedindolesfortheselectiveinhibitionofcyclooxygenaseacomputationalexpedition
AT mohammadmostafa molluscderivedbrominatedindolesfortheselectiveinhibitionofcyclooxygenaseacomputationalexpedition
AT leiliu molluscderivedbrominatedindolesfortheselectiveinhibitionofcyclooxygenaseacomputationalexpedition
AT kirstenbenkendorff molluscderivedbrominatedindolesfortheselectiveinhibitionofcyclooxygenaseacomputationalexpedition